/
/
/

Syncom Formulations (India) Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)21.17
Volume (₹)52.34 L
High (₹)21.32
Upper Circuit25.16
Low (₹)20.15
Lower Circuit16.78
Prev Close20.97
52W High (₹)22.59
Price20.23
52W Low (₹)10.21

Share Market Cap & Key Ratios Overview

M.Cap (₹)1972.12 Cr
Div. Yield (%)0.00
PE Ratio23.06
Debt to Equity0.01
Price to Book4.52
Book Value3.64
EPS (TTM)0.91
Face Value1.00
ROE (%)15.69

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
SYNCOMFNSE
LTP
1W Low
1W High
Market cap (₹)
1868.5-30.5 (-1.61%)
1866.20
1907.80
4,51,339Cr
9490+390 (4.29%)
9119.50
9615
2,54,068Cr
4946+89 (1.83%)
4823
4992
1,88,767Cr
1127.7+7.7 (0.69%)
1114.10
1167.70
1,14,713Cr
1370-15 (-1.08%)
1368.90
1398.40
1,11,804Cr
1934.6+94.6 (5.14%)
1832.70
1955
1,05,118Cr
1679.5+26.4 (1.60%)
1646
1704
97,009Cr
2098.2-11.8 (-0.56%)
2091
2135.50
96,575Cr
1144.9-6.1 (-0.53%)
1136.40
1163.20
96,113Cr
2270.7-57.2 (-2.46%)
2270
2331.60
95,242Cr
20.23-0.35 (-1.70%)
19.73
21.50
1,972Cr

Key Highlights of Syncom Formulations (India) Ltd Balance Sheet

Syncom Formulations (India) Ltd balance sheet discloses shareholders' funds of ₹94Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹94Cr, and the reserves and surplus of the company is ₹245.9Cr.

The company has its non-current liabilities with total liabilities of ₹412.1Cr as of 2025-03-31.

The current liabilities are ₹60.38Cr as of 2025-03-31. At the same time, current assets are ₹269.88Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹3.65Cr and tangible assets of ₹77.57Cr, provided in the Syncom Formulations (India) Ltd financial statements.